NEW YORK – Nautilus Biotechnology is looking to capitalize on the growing trend in proteomics to use machine learning to develop lower-cost, higher-throughput, and more complete proteomic analyses than are possible with existing technologies.
The San Carlos, California-based company last week said that it raised $76 million in Series B funding, bringing its total funding to date to more than $100 million.
Get the full story with
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Credit: Google News